» Articles » PMID: 35861243

PSMC1 Variant Causes a Novel Neurological Syndrome

Abstract

Proteasome 26S, the eukaryotic proteasome, serves as the machinery for cellular protein degradation. It is composed of the 20S core particle and one or two 19S regulatory particles, composed of a base and a lid. To date, several human diseases have been associated with mutations within the 26S proteasome subunits; only one of them affects a base subunit. We now delineate an autosomal recessive syndrome of failure to thrive, severe developmental delay and intellectual disability, spastic tetraplegia with central hypotonia, chorea, hearing loss, micropenis and undescended testes, as well as mild elevation of liver enzymes. None of the affected individuals achieved verbal communication or ambulation. Ventriculomegaly was evident on MRI. Homozygosity mapping combined with exome sequencing revealed a disease-associated p.I328T PSMC1 variant. Protein modeling demonstrated that the PSMC1 variant is located at the highly conserved putative ATP binding and hydrolysis domain, and is suggested to interrupt a hydrophobic core within the protein. Fruit flies in which we silenced the Drosophila ortholog Rpt2 specifically in the eye exhibited an apparent phenotype that was highly rescued by the human wild-type PSMC1, yet only partly by the mutant PSMC1, proving the functional effect of the p.I328T disease-causing variant.

Citing Articles

Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.

Goldbach-Mansky R, Alehashemi S, de Jesus A Nat Rev Rheumatol. 2024; 21(1):22-45.

PMID: 39623155 DOI: 10.1038/s41584-024-01184-8.


Understanding neurodevelopmental proteasomopathies as new rare disease entities: A review of current concepts, molecular biomarkers, and perspectives.

Cuinat S, Bezieau S, Deb W, Mercier S, Vignard V, Isidor B Genes Dis. 2024; 11(6):101130.

PMID: 39220754 PMC: 11364055. DOI: 10.1016/j.gendis.2023.101130.


Exploring the origins of neurodevelopmental proteasomopathies associated with cardiac malformations: are neural crest cells central to certain pathological mechanisms?.

Vignard V, Baruteau A, Toutain B, Mercier S, Isidor B, Redon R Front Cell Dev Biol. 2024; 12:1370905.

PMID: 39071803 PMC: 11272537. DOI: 10.3389/fcell.2024.1370905.


PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response.

Deb W, Rosenfelt C, Vignard V, Papendorf J, Moller S, Wendlandt M Am J Hum Genet. 2024; 111(7):1352-1369.

PMID: 38866022 PMC: 11267520. DOI: 10.1016/j.ajhg.2024.05.016.


Proteasome-Associated Syndromes: Updates on Genetics, Clinical Manifestations, Pathogenesis, and Treatment.

Zhang J, Tao P, Deuitch N, Yu X, Askentijevich I, Zhou Q J Clin Immunol. 2024; 44(4):88.

PMID: 38578475 DOI: 10.1007/s10875-024-01692-y.


References
1.
Schrader E, Harstad K, Matouschek A . Targeting proteins for degradation. Nat Chem Biol. 2009; 5(11):815-22. PMC: 4228941. DOI: 10.1038/nchembio.250. View

2.
Pace C, Scholtz J, Grimsley G . Forces stabilizing proteins. FEBS Lett. 2014; 588(14):2177-84. PMC: 4116631. DOI: 10.1016/j.febslet.2014.05.006. View

3.
Fort P, Kajava A, Delsuc F, Coux O . Evolution of proteasome regulators in eukaryotes. Genome Biol Evol. 2015; 7(5):1363-79. PMC: 4453063. DOI: 10.1093/gbe/evv068. View

4.
Humbard M, Maupin-Furlow J . Prokaryotic proteasomes: nanocompartments of degradation. J Mol Microbiol Biotechnol. 2013; 23(4-5):321-34. PMC: 3936408. DOI: 10.1159/000351348. View

5.
Eno C, Graakjaer J, Svaneby D, Nizon M, Kianmahd J, Signer R . 14q32.11 microdeletion including CALM1, TTC7B, PSMC1, and RPS6KA5: A new potential cause of developmental and language delay in three unrelated patients. Am J Med Genet A. 2021; 185(5):1519-1524. DOI: 10.1002/ajmg.a.62117. View